Dendritic cell (DC)-based immunotherapy has been hampered by the lack of suitable methods for antigen delivery. Here, we use biodegradable poly(d,l-lactide-co-glycolide) microspheres (PLGA-MS) as carriers of peptides and proteins for antigen delivery to human monocyte-derived DC (MoDC). Compared to soluble proteins, MHC classes I and II-restricted presentation of PLGA-MS-encapsulated proteins and peptides by MoDC was markedly prolonged and proteins were presented 50-fold more efficiently on class I molecules. The vaccination of mice with DC loaded with PLGA-MS-encapsulated proteins raised strong and persisting cytotoxic T cell responses. In conclusion, antigen delivery via PLGA-MS markedly enhanced the duration of antigen presentation by hu...
Degradable polyelectrolyte microcapsules (PMs; see picture) as antigen delivery vehicles are taken u...
Peptide based vaccines may suffer from limited stability and inefficient delivery to professional an...
Abstract Background Developing safe and effective cancer vaccine formulations is a primary focus in ...
Dendritic cells (DC) are increasingly explored as cellular vaccines for tumor immunotherapy. In most...
Biodegradable microspheres (MS) consisting of poly(D,L-lactide-co-glycolide) (PLGA) represent a prom...
With emerging success in fighting off cancer, chronic infections, and autoimmune diseases, immunothe...
Poly(lactic-co-glycolic acid) (PLGA) particles have been extensively studied as biodegradable delive...
Abstract Background Many peptide-based cancer vaccines have been tested in clinical trials with a li...
Poly(lactic-co-glycolic acid) (PLGA) particles have been extensively studied as biodegradable delive...
Background: Peptide based vaccines may suffer from limited stability and inefficient delivery to pro...
Dendritic cells phagocytose pathogens leading to maturation and cross-presentation on MHC class I. W...
Dendritic cells phagocytose pathogens leading to maturation and cross-presentation on MHC class I. W...
Vaccine efficacy is strongly enhanced by antibody-mediated targeting of vaccine components to dendri...
Biodegradable microspheres (MS) based on poly(D,L-lactide) and poly(D,L-lactide-coglycolide) have th...
We have previously reported that biodegradable polymer microspheres (MS) are capable of eliciting st...
Degradable polyelectrolyte microcapsules (PMs; see picture) as antigen delivery vehicles are taken u...
Peptide based vaccines may suffer from limited stability and inefficient delivery to professional an...
Abstract Background Developing safe and effective cancer vaccine formulations is a primary focus in ...
Dendritic cells (DC) are increasingly explored as cellular vaccines for tumor immunotherapy. In most...
Biodegradable microspheres (MS) consisting of poly(D,L-lactide-co-glycolide) (PLGA) represent a prom...
With emerging success in fighting off cancer, chronic infections, and autoimmune diseases, immunothe...
Poly(lactic-co-glycolic acid) (PLGA) particles have been extensively studied as biodegradable delive...
Abstract Background Many peptide-based cancer vaccines have been tested in clinical trials with a li...
Poly(lactic-co-glycolic acid) (PLGA) particles have been extensively studied as biodegradable delive...
Background: Peptide based vaccines may suffer from limited stability and inefficient delivery to pro...
Dendritic cells phagocytose pathogens leading to maturation and cross-presentation on MHC class I. W...
Dendritic cells phagocytose pathogens leading to maturation and cross-presentation on MHC class I. W...
Vaccine efficacy is strongly enhanced by antibody-mediated targeting of vaccine components to dendri...
Biodegradable microspheres (MS) based on poly(D,L-lactide) and poly(D,L-lactide-coglycolide) have th...
We have previously reported that biodegradable polymer microspheres (MS) are capable of eliciting st...
Degradable polyelectrolyte microcapsules (PMs; see picture) as antigen delivery vehicles are taken u...
Peptide based vaccines may suffer from limited stability and inefficient delivery to professional an...
Abstract Background Developing safe and effective cancer vaccine formulations is a primary focus in ...